Stem Cells: Unlocking the Potential - Program

 

8:00 am
Continental Breakfast

8:45 am
Opening Remarks
Ilse Treurnicht
Chief Executive Officer, MaRS Discovery District, Canada
9:00 am
Annemarie Moseley
Acting Chief Executive Officer, Aggregate Therapeutics Inc., Canada
"The Commercialization of Stem Cell Research: Historic and Current Challenges"
9:30 am
Thomas B. Okarma
President, Chief Executive Officer, and Director, Geron Corporation, USA
"Human Embryonic Stem Cells: Promise and Progress"
10:00 am
Laura Grey
Vice President, Research Strategy and Business Development, Insception Biosciences Inc., Canada
"Harnessing the Potential of Stem Cells from Cord Blood"
10:20 am
Coffee Break
11:00 am
Cheryl V. Reicin
Partner, Torys LLP (Practice Leader of the Technology and Life Sciences Group), Canada
"The Venture Capital Perspective: Canada and the USA"
11:30 am
Ross Tubo
Senior Director, Stem Cell Biology, Genzyme Corporation, USA
"Cellular Therapies: Genzyme's History and Perspective"
11:50 am
Jan Alfheim
President, StemPath Inc., Canada
"Developing Regenerative Medicines for Cardiac and Skeletal Myopathies"
12:20 pm
Lunch
1:45 pm
Stephen L. Minger
Director, Stem Cell Biology Laboratory, Wolfson Centre for Age Related Diseases, King's College, England
"Therapeutic Applications of Human Stem Cells"
2:15 pm
Janet Rossant
Research Institute, Hospital for Sick Children and the University of Toronto Department of Medical Genetics and Microbiology, Canada
"Stem Cells from the Blastocyst: Mouse-Human Comparisons"
2:45 pm
Mick Bhatia
Director and Scientist, Stem Cell Biology and Regenerative Medicine,
The Krembil Centre for Stem Cell Biology, Robarts Research Institute, Canada
"Unique Challenges of Human Embryonic Stem Cell Lines"
3:15 pm
Coffee Break
3:45 pm
Michael A. Rudnicki
Senior Scientist and Director, Molecular Medicine Program,
Ottawa Health Research Institute, Canada
"Molecular Regulation of Myogenic Stem Cell Function during Regenerative Myogenesis"
4:15 pm
Closing Remarks
Christian Burks
President and Chief Executive Officer, Ontario Genomics Institute, Canada
5:00 pm
Reception